Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments

Tae Heung Kang, Jin Hyup Lee, Kyung Hee Noh, Hee Dong Han, Byung Cheol Shin, Eun Young Choi, Shiwen Peng, Chien Fu Hung, T. C. Wu, Tae Woo Kim

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Dendritic cell (DC)-based vaccines have become important in immunotherapeutics as a measure for generating antitumor immune responses. We have previously demonstrated that linkage of the antigen gene to a lysosomal targeting signal, a sorting signal of the lysosome-associated membrane protein type 1 (LAMP-1), enhances the potency of DC-based vaccines. DCs have a limited life span, hindering their long-term ability to prime antigen-specific T cells. In this study, we attempted to further improve the potency of a DC vaccine that targets human papilloma virus 16 (HPV16) E7 to a lysosomal compartment (DC-Sig/E7/LAMP-1) by combining a strategy to prolong DC life. We show that small interfering RNA-targeting Bak and Bax proteins can be used to allow transfected DCs to resist being killed by T cells. This is done by downregulating these proapoptotic proteins, which have been known as so-called gate keepers in mitochondria-mediated apoptosis. DCs expressing intact E7 or Sig/E7/LAMP-1 became resistant to attack by CD8+ T cells after transfection with BAK/BAX siRNA, leading to enhanced E7-specific T cell activation in vitro and in vivo. More importantly, vaccination with E7-presenting DCs transfected with BAK/BAX siRNA generated a strong therapeutic effect against an E7-expressing tumor in vaccinated mice, compared with DCs transfected with control siRNA. Our data indicate that a combination of strategies to enhance intracellular Ag processing and to prolong DC life may offer a promising strategy for improving DC vaccine potency.

Original languageEnglish
Pages (from-to)1696-1703
Number of pages8
JournalInternational Journal of Cancer
Volume120
Issue number8
DOIs
Publication statusPublished - 2007 Apr 15

Fingerprint

Vaccine Potency
Dendritic Cells
Small Interfering RNA
Antigens
Lysosome-Associated Membrane Glycoproteins
T-Lymphocytes
bcl-2 Homologous Antagonist-Killer Protein
Vaccines
Papillomavirus Vaccines
bcl-2-Associated X Protein
Therapeutic Uses
Transfection
Mitochondria
Vaccination
Down-Regulation
Apoptosis

Keywords

  • BAK
  • BAX
  • Dendritic cell
  • Immunotherapy
  • Sig/E7/LAMP-1
  • siRNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments. / Kang, Tae Heung; Lee, Jin Hyup; Noh, Kyung Hee; Han, Hee Dong; Shin, Byung Cheol; Choi, Eun Young; Peng, Shiwen; Hung, Chien Fu; Wu, T. C.; Kim, Tae Woo.

In: International Journal of Cancer, Vol. 120, No. 8, 15.04.2007, p. 1696-1703.

Research output: Contribution to journalArticle

Kang, Tae Heung ; Lee, Jin Hyup ; Noh, Kyung Hee ; Han, Hee Dong ; Shin, Byung Cheol ; Choi, Eun Young ; Peng, Shiwen ; Hung, Chien Fu ; Wu, T. C. ; Kim, Tae Woo. / Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments. In: International Journal of Cancer. 2007 ; Vol. 120, No. 8. pp. 1696-1703.
@article{9959c582b48048f3a34be2ed2b55be37,
title = "Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments",
abstract = "Dendritic cell (DC)-based vaccines have become important in immunotherapeutics as a measure for generating antitumor immune responses. We have previously demonstrated that linkage of the antigen gene to a lysosomal targeting signal, a sorting signal of the lysosome-associated membrane protein type 1 (LAMP-1), enhances the potency of DC-based vaccines. DCs have a limited life span, hindering their long-term ability to prime antigen-specific T cells. In this study, we attempted to further improve the potency of a DC vaccine that targets human papilloma virus 16 (HPV16) E7 to a lysosomal compartment (DC-Sig/E7/LAMP-1) by combining a strategy to prolong DC life. We show that small interfering RNA-targeting Bak and Bax proteins can be used to allow transfected DCs to resist being killed by T cells. This is done by downregulating these proapoptotic proteins, which have been known as so-called gate keepers in mitochondria-mediated apoptosis. DCs expressing intact E7 or Sig/E7/LAMP-1 became resistant to attack by CD8+ T cells after transfection with BAK/BAX siRNA, leading to enhanced E7-specific T cell activation in vitro and in vivo. More importantly, vaccination with E7-presenting DCs transfected with BAK/BAX siRNA generated a strong therapeutic effect against an E7-expressing tumor in vaccinated mice, compared with DCs transfected with control siRNA. Our data indicate that a combination of strategies to enhance intracellular Ag processing and to prolong DC life may offer a promising strategy for improving DC vaccine potency.",
keywords = "BAK, BAX, Dendritic cell, Immunotherapy, Sig/E7/LAMP-1, siRNA",
author = "Kang, {Tae Heung} and Lee, {Jin Hyup} and Noh, {Kyung Hee} and Han, {Hee Dong} and Shin, {Byung Cheol} and Choi, {Eun Young} and Shiwen Peng and Hung, {Chien Fu} and Wu, {T. C.} and Kim, {Tae Woo}",
year = "2007",
month = "4",
day = "15",
doi = "10.1002/ijc.22377",
language = "English",
volume = "120",
pages = "1696--1703",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments

AU - Kang, Tae Heung

AU - Lee, Jin Hyup

AU - Noh, Kyung Hee

AU - Han, Hee Dong

AU - Shin, Byung Cheol

AU - Choi, Eun Young

AU - Peng, Shiwen

AU - Hung, Chien Fu

AU - Wu, T. C.

AU - Kim, Tae Woo

PY - 2007/4/15

Y1 - 2007/4/15

N2 - Dendritic cell (DC)-based vaccines have become important in immunotherapeutics as a measure for generating antitumor immune responses. We have previously demonstrated that linkage of the antigen gene to a lysosomal targeting signal, a sorting signal of the lysosome-associated membrane protein type 1 (LAMP-1), enhances the potency of DC-based vaccines. DCs have a limited life span, hindering their long-term ability to prime antigen-specific T cells. In this study, we attempted to further improve the potency of a DC vaccine that targets human papilloma virus 16 (HPV16) E7 to a lysosomal compartment (DC-Sig/E7/LAMP-1) by combining a strategy to prolong DC life. We show that small interfering RNA-targeting Bak and Bax proteins can be used to allow transfected DCs to resist being killed by T cells. This is done by downregulating these proapoptotic proteins, which have been known as so-called gate keepers in mitochondria-mediated apoptosis. DCs expressing intact E7 or Sig/E7/LAMP-1 became resistant to attack by CD8+ T cells after transfection with BAK/BAX siRNA, leading to enhanced E7-specific T cell activation in vitro and in vivo. More importantly, vaccination with E7-presenting DCs transfected with BAK/BAX siRNA generated a strong therapeutic effect against an E7-expressing tumor in vaccinated mice, compared with DCs transfected with control siRNA. Our data indicate that a combination of strategies to enhance intracellular Ag processing and to prolong DC life may offer a promising strategy for improving DC vaccine potency.

AB - Dendritic cell (DC)-based vaccines have become important in immunotherapeutics as a measure for generating antitumor immune responses. We have previously demonstrated that linkage of the antigen gene to a lysosomal targeting signal, a sorting signal of the lysosome-associated membrane protein type 1 (LAMP-1), enhances the potency of DC-based vaccines. DCs have a limited life span, hindering their long-term ability to prime antigen-specific T cells. In this study, we attempted to further improve the potency of a DC vaccine that targets human papilloma virus 16 (HPV16) E7 to a lysosomal compartment (DC-Sig/E7/LAMP-1) by combining a strategy to prolong DC life. We show that small interfering RNA-targeting Bak and Bax proteins can be used to allow transfected DCs to resist being killed by T cells. This is done by downregulating these proapoptotic proteins, which have been known as so-called gate keepers in mitochondria-mediated apoptosis. DCs expressing intact E7 or Sig/E7/LAMP-1 became resistant to attack by CD8+ T cells after transfection with BAK/BAX siRNA, leading to enhanced E7-specific T cell activation in vitro and in vivo. More importantly, vaccination with E7-presenting DCs transfected with BAK/BAX siRNA generated a strong therapeutic effect against an E7-expressing tumor in vaccinated mice, compared with DCs transfected with control siRNA. Our data indicate that a combination of strategies to enhance intracellular Ag processing and to prolong DC life may offer a promising strategy for improving DC vaccine potency.

KW - BAK

KW - BAX

KW - Dendritic cell

KW - Immunotherapy

KW - Sig/E7/LAMP-1

KW - siRNA

UR - http://www.scopus.com/inward/record.url?scp=33947148205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947148205&partnerID=8YFLogxK

U2 - 10.1002/ijc.22377

DO - 10.1002/ijc.22377

M3 - Article

C2 - 17230516

AN - SCOPUS:33947148205

VL - 120

SP - 1696

EP - 1703

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 8

ER -